Tony Bernazard screwed up Mets hitters

0 Comments

Bernazard.jpgRemember that guy who left your office last year, and when they went and cleaned out his office they found all those files he’d been screwing up for the past couple of years without anyone really knowing it?  Yeah, the Mets had one of those dudes:

Sources say [Tony] Bernazard, who oversaw minor-league development, was so
insistent on players hitting the ball to the opposite field that minor
leaguers were scolded for pulling the ball, sometimes even when they
got a hit . . . The intentions were good but the methods were extreme. In spring
training players took 80 swings a day against curve balls from a
pitching machine, hitting the ball the other way. The drills, which
continued at a modified number during the season, were emphasized to
the point that players eventually thought they were silly, and perhaps
even detrimental.

There could be some value in emphasizing opposite field hitting — Jeff Francoeur notes in the article that it may have helped him, which makes some sense for a guy who tries to jump on every pitch — but a one-size fits all approach to hitting is moronic.  Do you really want to turn David Wright into a slap hitter?  How much of his problems last year were the result of those 80 opposite-field swings a day?

Between this and all the other stuff he did after his buddy Omar Minaya hired him, Bernazard stands as the best argument there is against giving jobs to your friends simply because they’re your friends.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
0 Comments

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.